RA Capital Nexus Fund IV, L.P. (CIK 2053586) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-06). Recent activity: Buy COAG (3.6M shares), Buy COAG (1.0M shares), Buy COAG (221,188 shares), Buy COAG (2.5M shares), Buy COAG (133,750 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-06 | Hemab Therapeutics Holdings, Inc. (COAG) | Director | Buy | 3.6M | $0 |
| 2026-05-06 | Hemab Therapeutics Holdings, Inc. (COAG) | Director | Buy | 1.0M | $0 |
| 2026-05-06 | Hemab Therapeutics Holdings, Inc. (COAG) | Director | Buy | 221,188 | $0 |
| 2026-05-06 | Hemab Therapeutics Holdings, Inc. (COAG) | Director | Buy | 2.5M | $45.7M |
| 2026-05-06 | Hemab Therapeutics Holdings, Inc. (COAG) | Director | Buy | 133,750 | $2.4M |
| 2026-05-06 | Hemab Therapeutics Holdings, Inc. (COAG) | Director | Buy | 87,143 | $2.1M |
| 2026-05-06 | Hemab Therapeutics Holdings, Inc. (COAG) | Director | Buy | 10,268 | $256,700 |
| 2026-05-06 | Hemab Therapeutics Holdings, Inc. (COAG) | Director | Buy | 14,611 | $347,303 |
| 2026-05-06 | Hemab Therapeutics Holdings, Inc. (COAG) | Director | Buy | 53,407 | $1.3M |
Source: SEC Form 4 filings · as of 2026-05-06